Forum tackles health outcomes that matter to patients, society beyond costs
An article published in the Manila Standard recently caught the attention of your Decide team. Following the gathering of 350 experts from the public and private sector around the theme of "health as an investment", the event was an occasion to think about HTA beyond cost-effectiveness, which remains a prominent driver of the process.
Participants whether decision makers in the health system or the pharmaceutical industry emphasised that:
Transparency, flexibility, stakeholder engagement, and patient access are key attributes of a well-functioning value assessment system.
To read the full article: click here.